Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Stryker Gains FDA Clearance for SAHARA Lateral 3D Expandable Interbody

      Stryker Sahara crop  
      SAHARA Lateral 3D Expandable Interbody System  

Stryker received FDA 510(k) clearance of the SAHARA® Lateral 3D Expandable Interbody System featuring Lamellar 3D Titanium Technology.

SAHARA Lateral is the first-ever 3D-printed lateral expandable fusion device. Its passive expansion capabilities are designed to allow surgeons to achieve up to 30 degrees of sagittal spinal correction. The implant can be adjusted from a lateral approach intraoperatively, or can adjust passively in a staged posterior approach following excision of bone.

Lamellar 3D Titanium Technology is a 3D printing method whereby implants are grown through selective application of a high-energy laser beam, creating complex internal geometries and a roughened surface architecture. The same technology was used to manufacture the MOJAVE posterior lumbar expandable interbody, launched by K2M in 2018 prior to the company's acquisition by Stryker.

SAHARA Lateral complements the SAHARA Anterior Lumbar Expandable Stabilization System, a lordotic expandable device with integrated screw fixation introduced by K2M in 2017. It was K2M's first expandable interbody device.